Skeletal muscle is a contractile, post-mitotic tissue composed of multinucleated muscle cells known as myofibres, which are formed by fusion of differentiated mononuclear muscle cells. Skeletal muscle accounts for 30-50% of body mass in humans and is one of the few organs that retains a highly adaptive and robust capacity to regenerate throughout most of life. Muscle regeneration depends on resident muscle stem cells known as satellite cells. These mesoderm-derived cells constitute a heterogeneous population of adult stem cells
, which are capable of both self-renewal and myogenic differentiation, and which reside in a specialized niche between the muscle sarcolemma and the basal lamina of individual myofibres 1 (FIG. 1) . The satellite cell niche is composed of both acellular and cellular components, including extracellular matrix proteins, growth factors, myofibres and muscle-resident non-myogenic cells such as fibro-adipogenic progenitors (FAPs), macrophages and regulatory T cells (Tregs) [2] [3] [4] [5] [6] [7] [8] [9] . Collectively, components of the satellite cell niche create a complex microenvironment that plays a crucial part in maintaining satellite cell identity and ensuring robust regenerative responses to muscle insult 2, [4] [5] [6] [7] [8] [9] . Previous studies have established the central importance of a regulated cascade of transcription factors that mediate satellite cell maintenance, activation and differentiation 3 . Satellite cells are distinguished from other mononuclear cells in muscle by expression of the canonical satellite cell regulator, paired box protein 7 (PAX7) 10, 11 . Satellite cells remain in quiescence (that is, in a non-dividing state) in uninjured muscle, which is often referred to as muscle homeostasis (FIG. 1) . However, these cells become activated upon muscle trauma, which promotes their subsequent proliferation and -for a subset of activated satellite cells -differentiation into fusion-competent myoblasts. Satellite cell activation is mediated in part by the induced expression of myogenic determination protein (MYOD) and myogenic factor 5 (MYF5) [12] [13] [14] [15] [16] [17] . The differentiation of committed myoblasts involves the downregulation of PAX7 and de novo expression of myogenin (also known as MYOG), which is followed by fusion of the differentiated myoblasts with each other and with any remaining myofibres to repair damaged muscle 18 . Activated satellite cells that do not commit to differentiation can downregulate MYOD and MYF5 and undergo self-renewing proliferation that replenishes the pool of muscle satellite cells, thereby ensuring that the capacity to respond to future injuries is maintained in the muscle 3, [19] [20] [21] (FIG. 1) .
Extensive evidence supports the notion that adult satellite cells are required for healthy muscle repair, and severe muscular and regenerative deficits result from their absence 22, 23 . Although there has been debate regarding the requirements for PAX7 in satellite cell maintenance and muscle repair 24 , recent efforts have confirmed an absolute requirement for PAX7 in satellite cell proliferation and self-renewal, and hence for efficient repair of muscle after injury [25] [26] [27] . Functional loss of the satellite cell pool has been observed in association with age-related muscle dysfunction and other muscle degenerative pathologies 28, 29 , highlighting the crucial need to maintain this unique cell population in order to sustain effective regenerative function over a lifetime.
The development of efficient methods to prospectively isolate satellite cells from skeletal muscle has fuelled progress in further delineating their regenerative functions in vivo. Satellite cells can be purified from muscle using protocols that combine chemical and mechanical dissociation of muscle and separation of mononuclear cells from fibres with fluorescenceactivated cell sorting (FACS), using positive and negative selection markers to enrich for myogenic popu lations 19, [30] [31] [32] . Various surface marker combinations have been reported to positively enrich for highly functional satellite cells, including CD34 and α7 integrin 19 , vascular cell adhesion protein 1 (VCAM1) 30, [33] [34] [35] , C-X-C chemokine receptor type 4 (CXCR4) and β1 integrin 36, 37 , neural cell adhesion molecule (NCAM; also known as CD56) 38, 39 , epidermal growth factor receptor (EGFR) 40 , and syndecan 3 or 4 (REF. 41 ). Whether these different surface marker sorting schemes yield identical myogenic populations has yet to be fully addressed; however, cells enriched by any of these methods can efficiently engraft skeletal muscle when transplanted into either injured or diseased muscle and can improve muscle strength and function 19, 37, 42 . Satellite cells transplanted into pre-injured, diseased muscle also repopulate the satellite cell niche and can contribute to future rounds of muscle repair 19, 37, 42 . These observations have raised enthusiasm for the possibility of utilizing satellite cells as a cellular source for regenerative medicine
. New insights into how these cells regulate self-renewal and differentiation decisions in vivo, and how ex vivo culture systems affect satellite cell fate, will certainly be required to achieve this goal.
In this Review, we discuss recent progress in our understanding of the intrinsic molecular mechanisms regulating satellite cell fate during muscle regener ation and ageing, and in the context of Duchenne muscular dystrophy (DMD), which is the most common and severe muscle pathology diagnosed in childhood. As the details of myogenic differentiation and function of satellite cells during embryonic development have been recently addressed elsewhere 3 , we focus here on adult satellite cells and the molecular networks governing their quiescence, activation and self-renewal as key stages of the satellite cell life cycle. We also highlight the crucial influence of extrinsic factors that can modulate satellite cell-intrinsic signalling to direct satellite cell fate decisions during muscle regeneration and ageing. We anticipate that further elucidation of the gene regulatory circuits that determine satellite cell fate will provide a molecular blueprint to establish novel therapies to treat the increasing numbers of individuals suffering from age-associated muscle dysfunction and muscular diseases that currently have no cure.
Satellite cell fate decisions
Careful regulation of satellite cell identity and myogenic commitment are essential for maintaining the muscle satellite cell pool and appropriately activating repair mechanisms in response to muscle damage. Here, we discuss recent advances that have defined crucial new effectors of satellite cell regulation that govern the maintenance of satellite cell quiescence, activation of proliferation and capacity for self-renewal.
Satellite cell quiescence. Satellite cell division is restrained in uninjured muscle through mechanisms that seem to enforce satellite cell quiescence during homeostasis. In this section, we discuss recent advances in the transcriptional, epigenetic and signalling pathways that control the quiescent state.
Quiescent satellite cells (QSCs) express PAX7 but lack MYOD and other markers that are associated with cellular proliferation 20, 43 (FIG. 1) . Satellite cells isolated from fresh muscle by FACS also express PAX7 and have low-to-undetectable levels of MYOD 19, 37, 42 . Given these molecular similarities, and to keep with convention in
Box 1 | Origin and heterogeneity of satellite cells
Most satellite cells in postnatal muscle originate from a population of embryonic precursors that express paired box protein 7 (PAX7) and/or the related PAX3. These embryonic precursors of adult muscle are of mesodermal origin and arise from a dorsal structure of the developing somite (known as the dermomyotome) 135, 136 . In the mouse, by embryonic day 16.5 to 18.5, a subset of myogenic progenitors in the dermomyotome migrates to its prospective niche (analogous to the niche of satellite cells in postnatal skeletal muscle), which is positioned between a primitive basal lamina structure and the myotome 135 . Shortly after birth, postnatal satellite cells expand extensively to accommodate organismal growth and begin acquiring characteristic molecular features, including expression of specific surface markers, and the emergence of distinct high-and low-cycling subpopulations 90 , an aspect of satellite cell heterogeneity in adult muscle that is discussed in more depth below.
We define muscle satellite cells as bona fide muscle stem cells that are capable of self-renewal and differentiation to produce myoblasts, which can then fuse (with each other, as well as with existing fibres) to generate myofibres. However, several lines of evidence indicate that satellite cells in postnatal muscle exhibit notable molecular and phenotypic heterogeneity that can influence the fate and function of individual cells within the satellite cell pool. Mouse molecular genetic tools have been particularly useful in delineating subsets of muscle satellite cells, suggesting the co-existence in this compartment of a population of committed progenitors that are ready for myogenic differentiation, and a distinct, self-renewing population that is capable of reconstituting the satellite cell niche 45, 82, 83, 90 . In one of the studies, Cre recombinasemediated lineage tracing was used to distinguish a minority of adult muscle satellite cells (~10% of the total pool) that were not marked by myogenic factor 5 (Myf5)-Cre, suggesting that they had never expressed Myf5. This study further showed that this subset of cells repopulates the satellite cell compartment more readily (compared to Myf5-expressing satellite cells) when transplanted into PAX7-null animals, indicating that these cells may retain more robust self-renewal capabilities 83 . Conversely, satellite cells that did experience Myf5 expression were more prone to myogenic differentiation in these in vivo engraftment assays 83 . In another study, satellite cells that expressed higher levels of Pax7 RNA (PAX7 hi cells), as determined by flow cytometry using a PAX7-GFP reporter mouse 82 , displayed slower cycling, lower metabolic activity and the exclusive capacity to replenish the entire complement of PAX7 hi and PAX7 low satellite cells following transplantation. Studies to determine whether satellite cells that have never expressed Myf5 are enriched in the PAX7 hi subset, or vice versa, have yet to be reported. Satellite cells have also been functionally segregated solely on the basis of their proliferative history, with several studies indicating that low-cycling satellite cells have a higher engraftment potential than high-cycling satellite cells when both populations are transplanted into injured animals 45, 90, 137 . These data clearly document phenotypic and functional heterogeneity within the satellite cell pool; however, how cells toggle between these potentially interchangeable states and how each subset is maintained and regulated during homeostasis and throughout regeneration remain areas of very active exploration.
PAX3
A member of the paired box protein family expressed in satellite cells in a few adult muscle groups, with a prominent role in embryonic myogenesis.
Somite
A division in the developing embryo consisting of paired blocks of paraxial mesoderm.
Myotome
The dorsal part of the somite in the developing embryo that gives rise to the skeletal muscle.
Cre recombinase-mediated lineage tracing
A molecular genetic technique used to trace each cell that has ever expressed a gene of interest, through gene-specific Cre-mediated recombination that leads to expression of a fluorescent reporter gene.
Active chromatin
Regions of the genome that are actively transcribed and are flanked by histone H3 trimethylation at Lys4 (H3K4me3).
the field 19, 33, 37, 42 , this Review refers to freshly isolated satellite cells as QSCs, while noting the likelihood that the process of satellite cell isolation from muscle may trigger some initiating events in satellite cell activation. Future studies to provide a better understanding of the very early molecular changes that signal satellite cell activation will help to clarify this issue.
Recent genome-wide RNA expression maps have revealed that QSCs possess a unique transcriptional profile that distinguishes them from their more activated progeny. QSCs express approximately 500 uniquely enriched genes that are involved in transcriptional control, negative regulation of the cell cycle (including several members of the Sprouty family) 44 , cell-cell adhesion, and extracellular matrix and lipid transporter activity 33, 34 . Although the functional importance of many of these genes is yet to be understood, it seems likely that this transcriptional programme inhibits QSC prolifer ation 44, 45 , anchors satellite cells in their anatomical niche 46 and provides mechanisms for the efficient transport and processing of lipids that are required for metabolic reactions characteristic of quies cent cells 47 . At the epigenetic level, nearly half of all protein-coding genes are marked by active chromatin, specifically, acquiring histone H3 Lys4 trimethylation (H3K4me3) 33, 48 . Interestingly, genes that are expressed at low levels in quiescent satellite cells but induced upon satellite cell activation exhibit this active histone mark, which probably indicates that these gene regions are in a 'poised' state, anticipating release from quiescence 33 . These results emphasize the notion that satellite cell quies cence should not be mistaken for a form of cellular dormancy or inactivity. Rather, it represents an actively maintained state, typified by a quiescence-specific gene expression programme that is poised to execute the transcriptional and epigenetic transformations that enable a rapid switch to activation following muscle trauma.
Given the central role of developmental signalling pathways in modulating stem cell behaviours, it is perhaps not surprising that NOTCH signalling plays a key part in promoting satellite cell quiescence [49] [50] [51] . The NOTCH gene family encodes four trans membrane proteins (NOTCH1, 2, 3 and 4) that bind to five distinct ligands 52 . Following receptor-ligand binding, NOTCH undergoes a series of proteolytic cleavages that leads to nuclear translocation of the NOTCH intracellular domain (NICD). In the nucleus, NICD interacts with downstream effector proteins, such as recom bining binding protein-Jκ (RBPJκ), to regulate the transcription of NOTCH target genes 52 . Supporting a role for NOTCH signalling in QSCs, Notch3 mRNA and NOTCH3 protein levels decline rapidly upon satellite cell activation 49 , and genetic deletion of RBPJκ causes loss of PAX7-expressing satellite cells in muscle sections, even in the absence of muscle injury. This loss of RBPJκ-deficient satellite cells has been attributed to the entry of these cells into the cell cycle and their subsequent differentiation 50 . Conversely, ectopic expression of NICD in cultured primary muscle myoblasts slowed cycling kinetics, upregulated PAX7 and suppressed MYOD, indicating that active NOTCH signalling is sufficient to programme at least some of the molecular and phenotypic aspects of quiescence 51 . Our understanding of the molecular mechanisms that link activated NOTCH with preserved quiescence is far from complete, but insights have been gained from studies indicating that NOTCH target genes, such as those encoding the HES and HEY families of transcription factors, can reduce Myod mRNA levels and thereby suppress myogenic commitment. In addition, RBPJκ and NICD can bind directly to the Pax7 promoter, leading to its transcriptional activation 51 . This enables PAX7 to further reduce MYOD protein stability through transcription-independent mechanisms 53, 54 (FIG. 2a) . Mechanisms to regulate NOTCH signalling include modulating expression of the ligand or the receptor. Recent data indicate that satellite cells lacking the forkhead box protein 3 (FOXO3) transcription factor have reduced levels of the NOTCH1 and NOTCH3 receptor RNAs. FOXO3-deficient satellite cells also proliferate faster and differentiate more readily in culture, consistent with a failure to preserve cellular quiescence. Mice with an inactivating Foxo3 deletion in satellite cells display markedly impaired muscle regeneration after two consecutive muscle injuries, perhaps owing to a failure of satellite cells to self-renew after the primary injury.
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These studies also raise the possibility that FOXO3 might promote either proliferation and/or survival of satellite cells during the transient amplification phase, as fewer PAX7-positive satellite cells were associated with centrally nucleated fibres 1 week after injury in these mice. Further supporting a potentially direct link between FOXO3 and NOTCH signalling in QSCs, ectopic expression of NICD in FOXO3-deficient satellite cells partially recovered QSC numbers in single-fibre assays 55 . Together, these results suggest that a key function of FOXO3 in satellite cells is to maintain NOTCH receptor expression, which is in turn essential for maintaining the quiescent state (FIG. 2a) . Future work should build upon these and other findings discussed elsewhere [56] [57] [58] to fully characterize crucial transcription factors, non-coding RNAs, epigenetic regulators and translational regulators that are required to enforce satellite cell quiescence.
Satellite cell activation.
Proper satellite cell activation is crucial to ensuring an adequate regenerative response after muscle injury. Upon muscle insult, QSCs are exposed to extrinsic, pro-myogenic stimuli, including fibroblast growth factor (FGF) 59, 60 , hepatocyte growth factor (HGF) 61, 62 , insulin-like growth factor 1 (IGF1) 63 and tumour necrosis factor-α (TNFα) 64, 65 , which activate intrinsic pathways that stimulate proliferation. It has been reported that the first cell division is the rate-limiting step in the conversion of satellite cells to a highly proliferative state 66 , which probably explains why the peak of satellite cell expansion occurs approximately 3-4 days after muscle injury in vivo 44 . In addition, the long delay in initiation of satellite cell division may hint at the possibility that QSCs transition through one or more intermediate cell states on the path to full activation
.
From an epigenetic perspective, the transition of satel lite cells to full activation requires the implementation of a highly specialized, epigenetic and regulatory gene expression programme 33, 34 . For example, freshly isolated activated satellite cells (ASCs) exhibit enriched expression of gene pathways that are involved in metabolic processes (BOX 4) , cell cycle progression, chemotaxis and immune system regulation 33, 34 , reflecting the need for satellite cells to grow in size, proliferate, migrate and interact with muscle-resident immune cells in the context of muscle repair. In addition, the chromatin of ASCs is uniquely altered from that of QSCs, with ASCs having more genes associated with the repressive H3K27me3 chromatin mark 67 . H3K27me3 is deposited by EZH2, the enzymatic unit of the Polycomb repressive complex 2 (PRC2), which functions during development to restrict alternative cell fates during lineage commitment 68 . Interestingly, pro-inflammatory cytokines secreted during muscle injury and repair can stimulate EZH2, which (in complex with the transcriptional regulator YYI) represses PAX7 expression in cultured satellite cells that have already begun downregulating PAX7, suggesting that EZH2 may play a part in mediating myogenic differentiation 69 . However, a subsequent study from the same group showed that genetic deletion of Ezh2 in PAX7-expressing satellite There has been tremendous excitement over the years about using satellite cells as a transplantable cell population that could restore the functional stem cell pool in aged and diseased muscle, for instance, in patients with Duchenne muscular dystrophy (DMD). One could envision a scenario in which satellite cells isolated from the patient are genetically corrected ex vivo 138 , expanded and transplanted back to promote therapeutic muscle repair (see the figure). However, a major obstacle to this approach is that these cells are very rare, encompassing only ~1% of the mononuclear cells associated with myofibres 37 . In addition, removal of satellite cells from their endogenous niche rapidly alters their cellular state and, ultimately, their functional capacity 42, [139] [140] [141] . New culture systems that more precisely mimic the in vivo environment are likely to prove essential for generating sufficient numbers of engraftable satellite cells. For example, it was shown that culturing satellite cells on soft hydrogels to mimic in vivo forces and recreate niche signals promotes enhanced cell survival and self-renewal. Although this approach is a definite improvement over standard culturing conditions, threefold more hydrogel-cultured satellite cells are needed to obtain as much as 50% of the engraftment achieved by freshly isolated cells 97, 139 . Re-establishing in culture the full functional potential of satellite cells will probably require a combination of extrinsic and intrinsic signals 57, 58, 142 . Cell delivery represents a second major impediment to the realization of cell therapeutic approaches in skeletal muscle. Two delivery strategies have been utilized so far: systemic and intramuscular delivery. Ideally, a stem cell therapy to combat disseminated muscle diseases such as DMD or sarcopenia would be compatible with systemic delivery. However, prior work shows that satellite cells delivered systemically into mice become trapped in other organs (lungs, kidney and spleen) 143 . Therefore, methods to achieve more efficient muscle 'homing' of satellite cells (similar to the homing properties of circulating immune cells The NICD-RBPJκ complex activates the expression of target genes, including those encoding the HES and HEY families of transcription factors, which inhibit myogenic determination protein (MYOD). RBPJκ and NICD also bind to the promoter of paired box 7 (Pax7) and induce its expression. PAX7 induction further downregulates MYOD through transcriptionindependent mechanisms. The forkhead box protein 3 (FOXO3; green circle) transcription factor can induce expression of NOTCH1 and NOTCH3 transmembrane proteins, which facilitates NOTCH signalling by ensuring that an adequate number of receptors are produced and shuttled to the cell membrane, where they can interact with available ligands in the local environment. Ab | Satellite cell entry into the cell cycle is inhibited through the activities of p27 KIP1 , which inhibits cyclin-dependent kinases (CDKs). B | After muscle injury, activated satellite cells detect pro-myogenic stimuli from the local environment and begin proliferation. Ba | Exposure to fibroblast growth factor 2 (FGF2) induces p38α/β MAPK activity, which inhibits the RNA-binding destabilizing protein tristetraprolin (TTP), leading to stabilization of the Myod mRNA. This allows MYOD protein to accumulate (purple circle) and induce expression of Cdc6, a DNA replication gene that promotes cell cycle entry and thus proliferation. Bb | Another activation regulator, myogenic factor 5 (MYF5), is post-transcriptionally repressed by microRNA miR-31, which sequesters Myf5 mRNA into RNA granules in quiescent satellite cells (QSCs) and prevents activation of MYF5 targets. Following muscle trauma, the RNA granules dissociate, miRNA-31 levels decrease, and MYF5 protein is produced and can activate target genes. Bc | The Myf5 gene is also transcriptionally regulated through the activities of CARM1 (pink circle), an Arg methyltransferase that methylates PAX7 (small purple circles on the light blue circle), leading to PAX7 association with the histone acetyltransferase complex (HAT; purple complex), and the induced expression of target genes (such as Myf5) in activated satellite cells (ASCs). C | Satellite cells are capable of self-renewal. Ca | A balance between self-renewal and differentiation of satellite cells is achieved by the mode of cell division. Apico-basal divisions generate one self-renewing cell (Myf5 -; red) and one differentiating cell (Myf5 + ; blue). By contrast, planar divisions (parallel to the muscle fibre) are symmetric and generate two daughters that retain self-renewal capabilities. Cb | Self-renewal of satellite cells can be followed by their return to quiescence. FOXO3 induces expression of NOTCH signalling genes, enabling a cascade of molecular events that lead to the inhibition of MYOD-mediated differentiation and blockade of cell cycle progression. Cc | The return to quiescence also requires Sprouty 1 (SPRY1), which is a Tyr kinase inhibitor that inhibits FGF signalling, thereby restricting cellular proliferation. The mammalian target of rapamycin complex 1. Part of a protein complex that controls protein synthesis by sensing nutrients, energy and metabolic products in the cell.
p38-α MAPK and p38-β MAPK
(p38α/β MAPK). Two isoforms of the p38 family of MAPKs, which has a seminal role in detecting extracellular signals from outside the cell and directing a cascade of phosphorylation events that activates downstream effectors and, ultimately, target gene expression. cells before injury hampers their proliferation and predisposes them to differentiate, ultimately impairing muscle repair after injury 70, 71 . These studies highlight the complex activities of epigenetic regulators at several stages in the satellite cell life cycle and the need to confirm findings from ex vivo systems using in vivo animal models. Nonetheless, these findings clearly support the importance of chromatin reorganization and repression of key target genes in satellite cells during the transition from a QSC to an ASC.
MYOD and MYF5 are 'master' transcription factors that are crucial for enforcing the unique regulatory gene expression programme ascribed to ASCs 72, 73 . MYOD and MYF5 are induced in satellite cells in vivo within 3 hours of cardiotoxin-mediated muscle injury, implicating them in the early stages of satellite cell activation 16 . Indeed, ex vivo knockdown of MYOD in satellite cells associated with muscle fibres reduced the expression of CDC6, which is a regulator of DNA replication, and blocked satellite cell entry into S phase 74 . The activities of MYOD and MYF5 may only partially overlap, as MYOD-null animals have a severe myogenic differentiation defect 14 , whereas in MYF5-null animals, proliferation is primarily impaired 15, 17 . Future studies should focus on elucidating the mechanisms by which MYOD can enable both proliferative expansion and myogenic differentiation in ASCs, and whether co-expression of MYF5 influences these cell fate decisions.
There has been great interest in identifying the relevant upstream regulators of MYOD and MYF5. Although MYOD protein is undetectable in QSCs, PAX7 and FOXO3 induce transcriptional activation at the Myod locus in these cells 75 , further highlighting that satellite cells are primed for activation, but also hinting towards the existence of post-transcriptional mechanisms to regulate MYOD protein levels in QSCs. Insight into such regulation was revealed when it was shown that p38-α MAPK and p38-β MAPK (p38α/β MAPK) is crucial for awakening QSCs into the prolifer ative state 76 . p38α/β MAPK are increased in proliferating satellite cells, in which they induce MYOD protein expression by inhibiting the RNA-destabilizing protein tristetraprolin (TTP) 76, 77 (FIG. 2b) . The activities of TTP in QSCs ensure that Myod mRNA is stabilized only as satellite cells transition to activation. Similar to MYOD, MYF5 can be regu lated both transcriptionally and posttranscriptionally, and its regulation is crucial for a rapid transition to the full ASC state [78] [79] [80] . For example, CARM1, which is an Arg methyltransferase enzyme, methylates PAX7 protein in satellite cells committed to myogenesis, leading to association of PAX7 with the histone methyltransferase (HMT) complex (which is composed of absent, small or homeotic 2-like (ASH2L), mixed-lineage leukaemia 1 or 2 (MLL1 or MLL2), WD repeat domain 5 (WDR5) and retinoblastoma-binding protein 5 (RBBP5)) and sub sequent gene activation of Myf5 (REF. 79 ). The HMT complex, which functions as a chromatin-interacting unit that recruits elements required for active transcription, has previously been shown to collaborate with PAX7 to induce target gene expression 81 (FIG. 2b) . Another study showed that Myf5 mRNA is post-transcriptionally repressed by microRNA miRNA-31 in QSCs, through a mechanism involving mRNA sequestration in cytoplasmic RNA granules 80 . These RNA granules disassemble upon satellite cell activation, leading to Myf5 mRNA release and subsequent robust protein expression 80 (FIG. 2b) .
Altogether, these studies highlight the complex regulation -involving signalling pathways, transcription factors, epigenetic regulators, RNA-binding proteins and non-coding RNAs -that is required for the transition from quiescence to the full ASC programme. Future studies should focus on a more detailed understanding of the earliest stages of satellite cell activation, to define more completely the complexity of how QSCs awaken and prepare for cell division. New investigations into these unexplored areas may provide insight into mechanisms that can be exploited to prime satellite cells for enhanced muscle repair in vivo, such as the newly described poised (G Alert ) state of these cells
Satellite cell self-renewal. The satellite cell population must self-renew to ensure that a sufficient number of reserve cells can seed future rounds of muscle repair. Current data indicate that most resident satellite cells enter the cell cycle in response to muscle injury, as the majority of PAX7-positive satellite cells in an injured muscle incorporate bromodeoxyuridine (BrdU) within the first 7 days of muscle regeneration 44 . Thus, to achieve self-renewal, a subpopulation of proliferating satellite cells must first avoid myogenic differentiation and then return to the QSC state to replenish the available pool of stem cells. In this section, we discuss the various modes Recently, a new satellite cell state -the G Alert state -was identified when quiescent stem cells (QSCs) were exposed to injury at a distance 66 . In this study, animals were subjected to muscle injury in one limb, and then activated satellite cells (ASCs) were isolated from the injured limb muscle and contralateral satellite cells (CSCs) were isolated from the contralateral, uninjured limb muscle. Interestingly, compared to QSCs, CSCs had a shortened time until their first division, were slightly larger in size and had higher quantities of functional mitochondria and increased mitochondrial DNA content. CSCs also showed a higher propensity to differentiate and fuse with damaged fibres in vivo when compared to QSCs 66 . However, CSCs were still less activated, according to most of the phenotypic criteria described above, than ASCs that were proximal to muscle injury 66 . Thus, it was proposed that CSCs had entered an 'alert' state, representing a discrete stage of the cell cycle. This state is characterized by an intermediate cellular programme that can be reversibly adopted by satellite cells as they anticipate a pending need for a rapid transition from quiescence to activation to enable efficient muscle repair 66 . Interestingly, entry into the G Alert state seems to require mTORC1, as genetic deletion of one of its inhibitors, TSC1 (tuberous sclerosis complex 1), induced acquisition of a G Alert phenotype in uninjured animals. Conversely, genetic deletion of RAPTOR (regulatory associated protein of mTOR), which is an adaptor protein required for mTORC1 activity 145 , impaired the G Alert phenotype in CSCs. Abrogation of hepatocyte growth factor (HGF) signalling inhibited the G Alert phenotype, indicating that secreted HGF in the local microenvironment 62 may be required for this alternative satellite cell state. Together, these data suggest that QSCs are highly responsive to extracellular damage cues and can execute somewhat pre-emptive alterations to their cellular phenotype that prime them for activation, enabling them to respond more rapidly to subsequent perturbations of muscle homeostasis in their vicinity. It will be interesting in future experiments to test whether the G Alert state is also required as an intermediate step for satellite cells responding directly to local muscle injury.
Symmetric cell division
The partitioning of cellular components during cell division that leads to two daughter cells that are molecularly and functionally identical.
Asymmetric cell division
The partitioning of cellular components during cell division that leads to two daughter cells that are molecularly and functionally distinct.
Oxidative phosphorylation (OXPHOS).
A metabolic pathway in which mitochondria oxidize nutrients to form ATP.
Autophagic flux
A measurement that can be used to quantify cellular autophagic activity.
of cellular division that have recently been shown to influence these crucial cell fate decisions, and then highlight recent progress in identifying novel regulators that drive the self-renewal process during muscle regeneration.
Adult muscle stem cells can undergo either symmetric cell division or asymmetric cell division (FIG. 2c) . The mode of division depends on the distribution of cellular components, signalling molecules and genetic material, and it is paramount in balancing the maintenance and differentiation of the muscle stem cell pool 76, [82] [83] [84] [85] [86] . For example, upon satellite cell activation, the template DNA strand used for DNA replication, the asymmetric determinant regulator NUMB and p38α/β MAPK signalling molecules can segregate asymmetrically to daughter cells, with those daughters that receive p38α/β MAPK acquiring a more committed (differentiated) state; the daughters that acquire NUMB and the template DNA strand (and not p38α/β MAPK) are destined to self-renew to replenish the QSC pool 76, 82, 84, 87 . The evolutionarily conserved PAR (partitioning defect ive) complex and the SCRIB (Scribbled) cell polarity complex 77, 88 are probable drivers of the asymmetric distribution pattern of p38α/β MAPK. It has also been suggested that satellite cells that have never expressed Myf5, as determined by Cre-based lineage tracing, represent a satellite stem cell population that divides asymmetrically, with the daughter that maintains contact with the basal lamina eventually acquiring a self-renewed state (remaining Myf5-negative) and the apical daughter becoming Myf5-positive and committing to differentiation 83 (FIG. 2c) . However, satellite cells can also self-renew using symmetric cell division through the activities of WNT7A signalling 83, 89 , or when the JAK-STAT (Janus kinase-signal transducer and activator of transcription) signalling pathway is genetically or pharmacologically impaired 85, 86 . Further studies will be needed to decipher the molecular determinants that regulate asymmetric versus symmetric satellite cell division, to determine whether these modes of cellular division occur concurrently in vivo and to identify additional intrinsic gene regulatory factors that must be distributed selectively to self-renewing satellite cells to stall their differentiation and enable their return to quiescence.
Some insight into the crucial factors that may promote satellite cell self-renewal has come from recent studies of a slow-dividing subpopulation of satellite cells that is established after birth and requires the cell cycle inhibitor CDKN1B (also known as p27 KIP1 ) for mainten ance 90 . Sprouty 1 (SPRY1), which is a membraneassociated inhibitor of receptor Tyr kinase signalling 91 , is expressed specifically in this slow-cycling subpopulation of satellite cells 45, 90 , and its genetic deletion in PAX7-expressing satellite cells led to a 50% reduction in the quiescent PAX7 + MYOD -population that is present after muscle regeneration 44 . Thus, SPRY1 function in satellite cells seems to be required for efficient return of a subset of ASCs to quiescence after muscle repair is complete (FIG. 2c) . SPRY1 probably slows cell division through inhibition of FGF signalling, which normally stimulates proliferation 45, 60 . FOXO3 also may play a part in the suppression of myogenic differentiation and the return to quiescence (FIG. 2c) , as FOXO3-deficient satellite cells were more prone to spontaneous myogenic differentiation, and mice carrying a Foxo3 deletion displayed reduced satellite cell numbers after one round of muscle regeneration 55 . Collectively, these data suggest a model whereby both FOXO3 and SPRY1, independently or in concert, suppress myogenic differentiation in self-renewing satellite cells and return these cells to the G 0 (QSC) state (FIG. 2c) . It is now important to identify upstream regulators of FOXO3 and SPRY1 and define the mechanism by which these factors are induced specific ally in self-renewing satellite cells during muscle regeneration. It will also be beneficial to pinpoint exactly when during the regeneration process these cell fate decisions -to self-renew or to differentiate -are made.
Satellite cell fate in ageing muscle
Muscle ageing is characterized by a decline in muscle repair and the progressive loss of muscle mass and function due to muscular atrophy, a process commonly referred to as sarcopenia. As elderly individuals represent the fastest-growing demographic in many nations, there is an urgent need to identify new therapeutics to boost
Box 4 | Metabolic sensing and control of satellite cell quiescence and activation
Muscle satellite cells undergo extreme changes in size and metabolic activity as they transition from a quiescent to a proliferating state 47 . In fact, even during homeostasis, heterogeneities in the metabolic status of quiescent satellite cells exist. For example, freshly isolated muscle satellite cells expressing lower levels of paired box 7 (Pax7) transcripts (suggestive of a more activated state) have higher levels of active mitochondria, ATP and mitochondrial transcription factor RNAs, indicating that an increase in oxidative phosphorylation (OXPHOS) may be required for satellite cell activation and proliferation 47, 82 . Increased mitochondrial activity is also found in satellite cells from mice subjected to short-term calorie restriction, a dietary regimen that has been shown to enhance muscle regenerative activity 146 . A direct functional link between metabolic state and the transition from satellite cell quiescence to activation has been unclear. However, it was recently reported that autophagic flux in quiescent satellite cells provides key bioenergetic resources needed for cell growth and proliferation during activation 147 . Interestingly, deletion of the gene encoding NAD-dependent deacetylase sirtuin 1 (Sirt1) in satellite cells led to a reduction in autophagy and, consequently, less active mitochondria, resulting in impairments in satellite cell proliferation 147 . The activities of SIRT1 in satellite cells are likely to be complicated, as it has also been reported that proliferating satellite cell-derived myoblasts in culture have reduced NAD + levels, rendering SIRT1 inactive, and that Sirt1 deletion in vivo led to precocious satellite cell differentiation 148 . As these two studies utilized different genetic systems for Sirt1 ablation (inducible versus constitutive), it may be that the timing of expression and cellular distribution of SIRT1, as well as potential compensatory mechanisms, underlie these seemingly contradictory observations.
In addition to modulating satellite cell entry and exit from the cell cycle, metabolic status may also directly influence the ability of these cells to support recovery from muscle damage, as well as the effectiveness of their transplantation. As noted above, satellite cells from calorie-restricted mice displayed enhanced oxygen consumption and mitochondrial activity. They were also more abundant and engrafted host muscle more efficiently upon transplantation 146 . These functional alterations suggest that metabolic reprogramming of quiescent satellite cells may promote their survival, as well as inducing their proliferation and/or differentiation -all properties that would increase the capacity of these cells to contribute to new and existing fibres. These data hint at exciting possibilities for enhancing muscle regenerative function through metabolic modulation. However, further investigations are needed to clarify the precise mechanisms through which metabolic shifts alter satellite cell function and to delineate additional key regulators of this process. 
Gastrocnemius muscle
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muscle repair and prevent muscle wasting and dysfunction. Although satellite cell dysfunction alone may be insufficient to drive the emergence of sarcopenia, misregulation of this cell population may promote increased muscle fibrosis and certainly impedes recovery after injury in older individuals [92] [93] [94] . It is increasingly apparent that intrinsic misregulation of gene pathways in ageing satellite cells leads to alterations in their proliferation and differentiation in vivo, impeding muscle regeneration. Likewise, extrinsic signals from the local niche and even circulating systemic factors can greatly influence muscle regenerative function and contribute to the decline of satellite cell regenerative function in aged muscle.
Intrinsic changes in ageing satellite cells. Recent studies have revealed crucial changes in the transcriptional and epigenetic landscape of QSCs as they age 33, 86, 95 . These analyses generally indicate that aged QSCs feature an increase in repressed chromatin states, with widespread H3K27me3 across the genome 33 , so it would not be surprising if these chromatin re-organization events were to contribute to the misregulation of key signalling pathways that are required for a robust regenerative response. Work in this area recently converged to highlight the crucial influence of overactive p38α/β MAPK signalling in aged satellite cells, which leads to a drastic decline in satellite cell self-renewal and impairs satellite cell function 96, 97 . A recent study showed that when as few as ten freshly isolated satellite cells from aged or young mice were intramuscularly transplanted into immunocompromised recipient mice, aged satellite cells engrafted (as defined by bioluminescence and histology) skeletal muscle at twothirds the rate of younger cells 97 . This difference was lost when higher numbers (between 100 and 300) of muscle satellite cells were transplanted, indicating that a subpopulation of aged satellite cells may retain high levels of functionality 98 . Interestingly, aged satellite cells exhibited a reduced proliferative output and were associated with elevated levels of p38α/β MAPK and senescence regulator genes, which could be reversed by pharmacological inhibition of p38α/β MAPK 97 . A parallel study demonstrated that the normal asymmetric partitioning of p38α/β MAPK signalling to satellite cell daughters is disrupted in aged cells, and that this disruption causes symmetric inheritance of p38α/β MAPK and impedes satellite cell selfrenewal (FIG. 3a) , which could be recovered by treatment with a small-molecule inhibitor of p38 signalling 96 . Another recent study found elevated levels of p16
INK4A
, an inhibitor of cyclin-dependent kinases (CDKs) 99 , in 'geriatric' satellite cells from 28-32-month-old mice. The elevation of p16 INK4A in these geriatric satellite cells led to their conversion from a reversibly quiescent to an irrevers ibly senescent state 95 . Paradoxically, in addition to its known role in satellite cell activation 76 , p38α/β MAPK signalling can also activate p16
INK4A to promote cellular senescence 99 . A genetic link between p38α/β MAPK and p16 INK4A was recently demonstrated in skeletal muscle, when it was found that p16
INK4A protein levels were reduced in the gastrocnemius muscle of animals expressing a dominant-negative p38α allele, although future studies will need to verify this connection in satellite cells 100 .
Cumulatively, these data suggest that an age-regulated intrinsic p38-signalling axis exists in the satellite cell pool. Under this model, whereas p38α/β MAPK is asymmetrically distributed to daughter cells in young satellite cells, the switch to symmetric p38α/β MAPK inheritance leads to a depletion of self-renewed satellite cells andthrough unknown mechanisms -activates p16 INK4A , driving cellular senescence (FIG. 3a) .
Finally, in two parallel studies, it was shown that JAK-STAT signalling and effector target genes have a pivotal role in myogenic commitment and differentiation, and that this pathway is misregulated in satellite cells of aged muscle 85, 86 . JAK-STAT target genes are elevated in 18-month-old mice relative to 3-month-old animals, and genetic perturbation of JAK and STAT family members in freshly isolated satellite cells from aged animals improved their functional engraftment when transplanted into host skeletal muscle. Short interfering RNA (siRNA) knockdown of JAK2 and STAT3 in satellite cells still associated with aged single fibres led to increases in the symmetric expansion of the PAX7 +
MYF5
-satellite stem cell population 86 . STAT3 is required for MYOD-mediated myogenic commitment ex vivo, and a transient pharmacological inhibition of STAT3 in aged animals in vivo increased the population of proliferating satellite cells and improved muscle regeneration 85 . Altogether, these data support a model in which elevated JAK-STAT signalling in aged satellite cells leads to their rapid differentiation and failure to undergo efficient symmetric expansion in response to muscle injury (FIG. 3a) .
In future studies, it will be useful to determine whether senescence is a state that all satellite cells will eventually reach, or rather a condition that only a subset of satellite cells will experience during muscle ageing. It will also be helpful to clarify whether p38α/β MAPK directly influences the senescent phenotype in ageing satellite cells. Furthermore, the role of JAK-STAT signalling in regulating cell fate decisions of muscle stem cells is probably context-dependent and is likely to vary among different JAK-STAT family members, as JAK-STAT proteins have been reported to promote satellite cell proliferation and prevent myogenic differentiation 101 , in addition to their role in promoting myogenic differentiation 85, 86 (discussed above). Future studies to generate genomic binding profiles and identify interacting partners of the various STAT transcription factors in young and aged satellite cells should shed light on their important functions during muscle regeneration and ageing.
Regulation by local factors. Satellite cells are greatly influenced by their local microenvironment, as muscle fibres and other non-myogenic cells secrete growth factors and cytokines that influence their behaviour during regeneration 3 . As satellite cells age, so does the niche in which they reside, and these structural and molecular alterations can impede satellite cell function. One example comes from a recent study showing that aged muscle secretes higher levels of FGF2 into the satellite cell niche, leading to consider able depletion of the low-cycling satellite cell popu lation. This study also reported that inhibition of FGF receptor 1 (FGFR1) can rescue age-related defects
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in satellite cell cycling and apoptosis 45 . Importantly, FGF2 was shown to inhibit the activities of SPRY1, which is a seminal regulator of satellite cell quiescence, explaining the shift towards more high-cycling satellite cells. Curiously, a different study found that the activity of FGFR1 was attenuated in aged satellite cells, and that ectopic expression of a constitutively active FGFR1 recombinant protein enhanced the asymmetric inheritance of p38α/β MAPK 96, 102 . As many signalling pathways exhibit bimodal or multimodal effects, which can be influenced by cellular context, timing and dosage, it is likely that these seemingly contradictory results reflect a crucial need to maintain FGF signalling in satellite cells within a tight physiological window, as over-activation or attenuation of this pathway can perturb muscle homeostasis and contribute to satellite cell dysfunction.
Together, these data provide an intriguing example of how ageing-related misregulation of extrinsic factors in the local niche can influence crucial intrinsic pathways that modify satellite cell fate.
Regulation by systemic signals. Evaluation of potential systemic influences on muscle regenerative function has been undertaken by several research groups using a 150-year-old technique known as parabiosis 103 , which involves the surgical joining of the circulatory systems of two mice. Remarkably, heterochronic parabiosis of young and aged mice led to the restoration of satellite cell activation and a more robust regenerative response after injury in the aged partner of the pair 104, 105 . These data provided initial support for the notion that young blood may contain 'rejuvenation factors' that are capable of regulating Nature Reviews | Molecular Cell Biology , upon activation, satellite cells (red circles) enter the cell cycle and asymmetrically distribute p38 to daughter cells, such that one daughter receives p38 and is competent for myogenic commitment and differentiation (blue circle with arrow pointing forwards to denote lineage commitment), whereas the other daughter self-renews and returns to the quiescent state (red circle with arrow pointing backwards to denote their self-renewal and return to quiescence). Asymmetric satellite cell divisions in young animals yield a healthy balance between satellite cells that are competent for myogenic differentiation and cells that self-renew during the expansion phase, which ensures the efficient repair of muscle and the return of a sufficient number of cells to the satellite cell niche to support future demands for muscle regeneration (homeostasis). However, in aged animals (18-24 months in mice), p38 is symmetrically partitioned to daughter cells and JAK-STAT (Janus kinase-signal transducer and activator of transcription) signalling is elevated in proliferating cells, leading to an overall increase in myogenic commitment within the satellite cell population and reducing the number of quiescent satellite cells at homeostasis. In 'geriatric' muscle (28-32 months in mice), p16
INK4A is also elevated in the satellite cell population, leading to a block in satellite cell activation and directing these cells to an irreversible state of cellular senescence (grey circles). The intrinsic deficits in aged and geriatric satellite cells deplete the self-renewing satellite cell population at homeostasis and thus impair the regenerative response in skeletal muscle as animals age (black triangle). b | Satellite cells from 2-month-old animals (adult) carrying a loss-of-function mutation in the dystrophin gene (mdx mice) display defects in asymmetric division and a stark reduction in apico-basally oriented divisions, owing to reduced levels of polarity kinase MARK2 (also known as PAR1B). This alters the localization of partitioning defective 3 (PARD3; shown in green) and impairs mitosis, leading to a failure to properly expand the lineage-committed satellite cells and a consequent inefficiency of muscle repair in response to injury. In mice carrying an alternative mdx allele (mdx 5cv)
, dystrophic satellite cells (either quiescent stem cells or activated stem cells) undergo a cell type transition towards a fibrogenic state (brown oval) via over-activation of WNT3A and transforming growth factor-β (TGFβ) signalling. This may, over time and in a context-dependent manner, lead to depletion of highly functional muscle stem cells. muscle repair in older animals. Importantly, the physiological impacts of heterochronic parabiosis are not limited to the aged partner, and exposure of a young animal to an aged circulation through such a pairing has been shown to slow regeneration in young muscle 92, 106, 107 . Thus, in addition to loss of pro-regenerative factors, aged blood seems to accumulate suppressive factors that can actively impair healthy function in the muscle and other organs.
Molecular identification of circulating molecules that regulate cell function in aged animals has been a major emphasis in recent years. Published reports implicate increases in transforming growth factor-β1 (TGFβ1) 108, 109 and WNT 92, 110 signalling as key contributors to the active suppression of satellite cell function in aged muscle, and these factors could potentially contribute to rare, age-related cell fate conversion events, in which satellite cells transition from a myogenic to a fibrogenic state 92, 111 . A few 'rejuvenating' molecules have also been identified. For example, it has been recently reported that oxytocin, which is a hormone produced by the hypothalamus with a demonstrated role in social behaviour 112 , is reduced threefold in the blood of aged mice, and that its receptor is downregulated by nearly 50% in aged satellite cells 113 . Administration of oxytocin to aged mice relieved the proliferation and differentiation defects of old satellite cells and enhanced the regenerative response to muscle injury 113 . In an intriguing and still-unexplained link to the studies of cell-intrinsic alterations in aged satellite cells discussed above, oxytocin induced the activation of the MAPK-ERK pathway in satellite cells and improved their proliferation potential. Similar beneficial effects on muscle repair following cryoinjury in ageing mice have been reported for the circulating cytokine growth differentiation factor 11 (GDF11), a member of the TGFβ superfamily that has significant structural and functional homology to myostatin (MSTN) 114 . Several studies suggest that expression of GDF11 declines with age in key GDF11-producing organs, and that the combined pool of GDF11 and MSTN is diminished in the blood of aged animals and humans [115] [116] [117] . Moreover, supplementation of recombinant GDF11 protein in older mice yielded improvements in muscle ultrastructure, satellite cell function and muscle regeneration 118 , supporting the notion that this protein, in particular, promotes healthier function in aged muscle. It is important to note, however, that these results were recently challenged by another group, who reported that GDF11 levels may increase with age in some species, and that GDF11 supplementation in old mice has no effect and may impede muscle regeneration in response to cardiotoxin injury in young mice 119 . These apparently discrepant results may relate to crossreactivity of reagents used to track GDF11 protein levels, which also react with GDF8 (REFS 119-121) and immunoglobulin light chain 116 , as well as to differences in experimental design, including differences in the modes of muscle injury used, in the doses of GDF11 injected, in the strategies for analysis of muscle regeneration employed, and even in the sources of GDF11 protein and aged animals that were used by the different groups. Although further studies have clarified some of the reported discrepancies 116 , additional experiments will be needed to fully recon cile these observations and determine how the levels of circulating GDF11 protein change throughout life, as well as how such changes influence satellite cells.
Satellite cells in muscular dystrophy
DMD is a severe genetic disorder that causes progressive muscle wasting in affected individuals and currently has no cure. Dystrophin, which is the defective gene product that causes DMD, has a pivotal structural role in anchoring the muscle fibre to the extracellular matrix in the muscle niche. Many studies in mice have shown that dystrophic fibres rupture and die after repeated muscle contractions and are eventually replaced with fibrotic tissue 122 . Fibrosis arises owing to an excess of connective tissue deposited in muscle during regenerative processes and is thought to be mediated, in part, by muscle-resident fibroblasts 123 . Most of the physiological and functional deficits exhibited by DMD patients have been attributed to abnormalities in mature muscle fibres, in which a role for dystrophin has been documented. However, recent work has shown that dystrophic satellite cells are impaired in various aspects of the satellite cell life cycle, which affects their muscle regener ative functions 37, 111, [124] [125] [126] [127] [128] [129] . We discuss here emerging data suggesting that intrinsic misregulation of satellite cell fate in dystrophic muscle may impair muscle regenerative function and contribute directly to DMD pathology.
Dystrophin functions near the cell membrane and is a structural component of the muscle cell that regulates the flow of signalling molecules. Therefore, it would not be surprising if a lack of dystrophin, which is normally expressed by satellite cells, directly influences their downstream cell-intrinsic signalling pathways to alter their fate and, ultimately, their function. Initial evidence that functional impairments in the satellite cell pool contribute to the DMD phenotype has been derived from a recent study that created a telomerase and dystrophin doubleknockout animal, mainly as a tool to impair the functional muscle stem cell pool 130 . These mice exhibit severe molecular and physiological defects in skeletal muscles, including the diaphragm 130 , similar to human patients with DMD. Interestingly, satellite cells from these mice showed reduced proliferation both in vivo and during ex vivo culturing, and they were functionally impaired when transplanted into host animals 130 . These data suggested, for the first time, that the severity of DMD can be influenced by the regenerative functions of endogenous muscle stem cells.
Evidence for a direct role of dystrophin in satellite cells remained elusive, however, until a recent study showed that the dystrophin protein has a highly specialized function in regulating cell division mechanisms in muscle stem cells 129 . Specifically, it was shown that the presence of dystrophin enhances Ser/Thr protein kinase MARK2 (also known as PAR1B) protein levels, and that MARK2 then mediates the asymmetric localization of the PARD3 polarity protein, which guides asymmetric cell division in proliferating satellite cells. Accordingly, in response to injury, dystrophic satellite cells undergo a prolonged mitosis and their ability to undergo apico-basal cell divisions is perturbed, leading to impaired asymmetric division and a smaller population of progenitors that are capable of contributing to muscle repair 129 (FIG. 3b) . Consistent with this, after culturing dystrophic muscle fibres for 72 hours, an increase in the subset of PAX7 + satellite cells that have never expressed Myf5 (REF. 83) (discussed above) and a reduction in the number of MYOG-expressing progenitors were observed, further suggesting that dystrophic satellite cells may have enhanced self-renewal and that some may be blocked with respect to myogenic differentiation 129 . These findings may explain why dystrophic muscle or single fibres contain more PAX7-positive satellite cells than control muscle or wild-type fibres 128, 131 . Interestingly, a prior report suggested that dystrophindeficient mice have defects in satellite cell self-renewal, with reduced numbers of PAX7 + MYF5 -satellite cells associated with single fibres from pre-injured animals 128 . As this effect was more pronounced in 6-month-old, as compared to 2-month-old (the approximate age used in the study discussed above) mice, these data may suggest that the effect of dystrophin deficiency on satellite cell self-renewal can vary with age. Alternatively, it is possible that these differences may be explained by the different activation models used -isolation of single fibres from pre-injured animals 128 versus single fibres from uninjured animals cultured for 72 hours 129 . Regardless, further studies are needed to harmonize these results.
Impaired self-renewal of the PAX7 + MYF5 -subpopulation of dystrophic satellite cells have also been associated with reduced NOTCH signalling, and enforced activation of this pathway restored satellite cell self-renewal 128 . Given the part that NOTCH plays in promoting satellite cell quies cence (discussed above), reduced NOTCH signalling in dystrophin-deficient satellite cells may also contribute to the reported increase in the high-cycling satellite cell subset in these animals 90 . The notion that modulation of NOTCH signalling may improve the dystrophic phenotype has gained further support from a very recent analy sis of two dystrophin-deficient dogs presenting a milder DMD phenotype 132, 133 . Intriguingly, these 'escaper' animals were found to possess a single mutation in the promoter sequence of the NOTCH ligand Jagged 1, which creates a novel myogenin-binding site and causes upregulation of Jagged 1 expression 133 . Myogenic cells from escaper dogs overexpressing Jagged 1 also showed enhanced proliferation, and further studies in dystrophic zebrafish confirmed that over-activation of Jagged 1 ameliorates the dystrophic phenotype 133 . These results demonstrate that studies aimed at revealing the mechanisms underlying the effects of Jagged 1 in dystrophic muscles, as well as delineating additional genetic suppressors of dystrophic phenotypes, may open novel treatment avenues for DMD.
Finally, it has been recently demonstrated that, apart from changes regarding their self-renewal and differentiation potential, a subset of dystrophic satellite cells may initiate a WNT3A-and TGFβ-dependent fibrogenic-like cellular programme (FIG. 3b) . Over time, this may deplete functional muscle stem cells and impede effective muscle repair. It also may help to explain the increase in fibrotic tissue seen in DMD muscle 111 . Collectively, the data discussed above strongly suggest that the loss of satellite cell regenerative function exacerbates DMD symptoms, and that dystrophin deficiency directly influences satellite cell fate. More studies will be required to fully understand the cellular and molecular mechanisms driving these apparently context-dependent effects 134 . It will also be important to decipher the transcriptional and epigenetic changes that may underlie functional misregulation in dystrophin-deficient satellite cells, and to determine the contributions of extrinsic signals to modulating these intrinsic changes to muscle stem cell fate.
Conclusions and perspective
An emerging theme from the work discussed here is that the intrinsic gene regulatory circuits that control adult muscle satellite cell behaviour in healthy muscle are misregulated in ageing and disease. Elucidating the transcriptional and epigenetic 'drivers' and their targets that function downstream of dystrophin deficiency or become altered in aged satellite cells will continue to reveal a molecu lar roadmap of potentially druggable targets that could be manipulated with small-molecule intervention to enable the modulation of stem cell activity. Furthermore, reinstating self-renewal pathways in cultured satellite cells may also enable their efficient expansion in culture, a barrier that currently impedes their use in the clinic
. There is no better time to study gene regulation, muscle stem cell fate and translational medicine, and we anticipate that novel discoveries in basic science will improve the prognosis and treatment of age-associated muscle dysfunction and currently incurable muscle pathologies.
